跳至主要内容
临床试验/CTRI/2022/09/045216
CTRI/2022/09/045216进行中(未招募)不适用

A prospective, Multicentric, cross-sectional study to evaluate the psychosocial status of patients with Type 2 Diabetes Mellitus and treating physician using Glycemic Happiness (GH) scale

Dr Reddys Laboratories Ltd30 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2022年5月9日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
400
试验地点
30
主要终点
To evaluate the psychosocial status of patients with Type 2 Diabetes Mellitus and treating physician using Glycemic Happiness (GH) scale

研究概览

简要总结

This survey is a A prospective, Multicentric, cross-sectional study to evaluate the psychosocial status of patients with Type 2 Diabetes Mellitus and treating physician using Glycemic Happiness (GH) scale in India. Patients with clinical diagnosis of Type 2 Diabetes Mellitus will be invited to take part in the survey. All participants will sign an Informed Consent Form to get enrolled in the survey. Investigator will collect all required data from the participants and complete the Case record form with available information.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • •1-Patients of either sex aged 18 years and above.
  • •2-Willing and able to sign Data Disclosure consent form.
  • •3-Patients with clinical diagnosis of Type 2 Diabetes Mellitus.

排除标准

  • •As this is cross-section study, exclusion criterias will not be applicable for this study.

结局指标

主要结局

To evaluate the psychosocial status of patients with Type 2 Diabetes Mellitus and treating physician using Glycemic Happiness (GH) scale

时间窗: Day-1 (Visit -1)

次要结局

  • To corelate the baseline demographic, disease characteristics (age, gender, duration of diabetes, risk factors etc.) and current T2DM management status with psychosocial health of patients with T2DM using GH scale(Day-1 (Visit -1))

研究者

申办方类型
Pharmaceutical industry-Indian

研究点 (30)

Loading locations...

相似试验